ITAM-coupled receptors inhibit IFNAR signaling and alter macrophage responses to TLR4 and Listeria monocytogenes

Journal of Immunology

Volumn 188, Issue 7, 2012, Pages 3447-3457

  Huynh, Linda ^a,b   Wang, Lu ^b,c   Shi, Chao ^a   Park Min, Kyung Hyun ^b   Ivashkiv, Lionel B ^a,b  

^a Weill Cornell Graduate School of Biomedical Sciences   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; BETA INTERFERON; BETA2 INTEGRIN; DECTIN 1; FC RECEPTOR; ITAM COUPLED RECEPTOR; JANUS KINASE; JANUS KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE; RECEPTOR; STAT PROTEIN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CELL DEATH; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; GENE; GENE ACTIVATION; GENE INDUCTION; HUMAN; HUMAN CELL; IL6 GENE; LISTERIA MONOCYTOGENES; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TNF GENE;

AMINO ACID MOTIFS; ANTIGENS, CD18; APOPTOSIS; AUTOCRINE COMMUNICATION; CELLS, CULTURED; CYTOKINES; HUMANS; INTERFERON TYPE I; JANUS KINASES; LISTERIA MONOCYTOGENES; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MONOCYTES; RECEPTOR, INTERFERON ALPHA-BETA; RECEPTORS, IMMUNOLOGIC; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; TOLL-LIKE RECEPTOR 4;

EID: 84859415424     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102211     Document Type: Article

References (48)

1. Hamerman, J. A., M. Ni, J. R. Killebrew, C.-L. Chu, and C. A. Lowell. 2009. The expanding roles of ITAM adapters FcRgamma and DAP12 in myeloid cells. Immunol. Rev. 232: 42-58.
2. Hamerman, J. A., and L. L. Lanier. 2006. Inhibition of immune responses by ITAM-bearing receptors. Sci. STKE 2006: re1.
3. Pasquier, B., P. Launay, Y. Kanamaru, I. C. Moura, S. Pfirsch, C. Ruffié, D. Hénin, M. Benhamou, M. Pretolani, U. Blank, and R. C. Monteiro. 2005. Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM. Immunity 22: 31-42. (Pubitemid 40143449)
4. Wang, L., R. A. Gordon, L. Huynh, X. Su, K.-H. Park Min, J. Han, J. S. Arthur, G. D. Kalliolias, and L. B. Ivashkiv. 2010. Indirect inhibition of Toll-like receptor and type I interferon responses by ITAM-coupled receptors and integrins. Immunity 32: 518-530.
5. Han, C., J. Jin, S. Xu, H. Liu, N. Li, and X. Cao. 2010. Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b. Nat. Immunol. 11: 734-742.
6. Pfirsch-Maisonnas, S., M. Aloulou, T. Xu, J. Claver, Y. Kanamaru, M. Tiwari, P. Launay, R. C. Monteiro, and U. Blank. 2011. Inhibitory ITAM signaling traps activating receptors with the phosphatase SHP-1 to form polarized "inhibisome"clusters. Sci. Signal. 4: ra24.
7. Mócsai, A., C. L. Abram, Z. Jakus, Y. Hu, L. L. Lanier, and C. A. Lowell. 2006. Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs. Nat. Immunol. 7: 1326-1333. (Pubitemid 46111254)
8. Abram, C. L., and C. A. Lowell. 2007. The expanding role for ITAM-based signaling pathways in immune cells. Sci. STKE 2007: re2.
9. Yamasaki, S., E. Ishikawa, M. Sakuma, H. Hara, K. Ogata, and T. Saito. 2008. Mincle is an ITAM-coupled activating receptor that senses damaged cells. Nat. Immunol. 9: 1179-1188.
10. Sancho, D., O. P. Joffre, A. M. Keller, N. C. Rogers, D. Martínez, P. Hernanz-Falcón, I. Rosewell, and C. Reis e Sousa. 2009. Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature 458: 899-903.
11. Osorio, F., and C. Reis e Sousa. 2011. Myeloid C-type lectin receptors in pathogen recognition and host defense. Immunity 34: 651-664.
12. Turnbull, I. R., J. E. McDunn, T. Takai, R. R. Townsend, J. P. Cobb, and M. Colonna. 2005. DAP12 (KARAP) amplifies inflammation and increases mortality from endotoxemia and septic peritonitis. J. Exp. Med. 202: 363-369. (Pubitemid 41126953)
13. Gantner, B. N., R. M. Simmons, S. J. Canavera, S. Akira, and D. M. Underhill. 2003. Collaborative induction of inflammatory responses by dectin-1 and Tolllike receptor 2. J. Exp. Med. 197: 1107-1117. (Pubitemid 36570066)
14. Rogers, N. C., E. C. Slack, A. D. Edwards, M. A. Nolte, O. Schulz, E. Schweighoffer, D. L. Williams, S. Gordon, V. L. Tybulewicz, G. D. Brown, and C. Reis e Sousa. 2005. Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity 22: 507-517. (Pubitemid 40545115)
15. Boulé, M. W., C. Broughton, F. Mackay, S. Akira, A. Marshak-Rothstein, and I. R. Rifkin. 2004. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J. Exp. Med. 199: 1631-1640. (Pubitemid 38821996)
16. Kagan, J. C., and R. Medzhitov. 2006. Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 125: 943-955. (Pubitemid 43795199)
17. Hamerman, J. A., J. R. Jarjoura, M. B. Humphrey, M. C. Nakamura, W. E. Seaman, and L. L. Lanier. 2006. Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J. Immunol. 177: 2051-2055. (Pubitemid 44200961)
18. Hamerman, J. A., N. K. Tchao, C. A. Lowell, and L. L. Lanier. 2005. Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12. Nat. Immunol. 6: 579-586. (Pubitemid 41710728)
19. Turnbull, I. R., S. Gilfillan, M. Cella, T. Aoshi, M. Miller, L. Piccio, M. Hernandez, and M. Colonna. 2006. Cutting edge: TREM-2 attenuates macrophage activation. J. Immunol. 177: 3520-3524. (Pubitemid 44359882)
20. Cao, W., D. B. Rosen, T. Ito, L. Bover, M. Bao, G. Watanabe, Z. Yao, L. Zhang, L. L. Lanier, and Y.-J. Liu. 2006. Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production. J. Exp. Med. 203: 1399-1405. (Pubitemid 43877601)
21. Ivashkiv, L. B. 2009. Cross-regulation of signaling by ITAM-associated receptors. Nat. Immunol. 10: 340-347.
22. Trinchieri, G. 2010. Type I interferon: friend or foe? J. Exp. Med. 207: 2053-2063.
23. Hamilton, M. J., F. Antignano, A. von Rossum, J.-L. Boucher, K. L. Bennewith, and G. Krystal. 2010. TLR agonists that induce IFN-beta abrogate resident macrophage suppression of T cells. J. Immunol. 185: 4545-4553.
24. Blanco, P., A. K. Palucka, M. Gill, V. Pascual, and J. Banchereau. 2001. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 294: 1540-1543. (Pubitemid 33063928)
25. Stetson, D. B., and R. Medzhitov. 2006. Type I interferons in host defense. Immunity 25: 373-381. (Pubitemid 44354218)
26. Stockinger, S., T. Materna, D. Stoiber, L. Bayr, R. Steinborn, T. Kolbe, H. Unger, T. Chakraborty, D. E. Levy, M. Müller, and T. Decker. 2002. Production of type I IFN sensitizes macrophages to cell death induced by Listeria monocytogenes. J. Immunol. 169: 6522-6529. (Pubitemid 36903504)
27. Pathak, M. K., and T. Yi. 2001. Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines. J. Immunol. 167: 3391-3397. (Pubitemid 32852583)
28. Potu, H., A. Sgorbissa, and C. Brancolini. 2010. Identification of USP18 as an important regulator of the susceptibility to IFN-alpha and drug-induced apoptosis. Cancer Res. 70: 655-665.
29. Shi, C., P. Velázquez, T. M. Hohl, I. Leiner, M. L. Dustin, and E. G. Pamer. 2010. Monocyte trafficking to hepatic sites of bacterial infection is chemokine independent and directed by focal intercellular adhesion molecule-1 expression. J. Immunol. 184: 6266-6274.
30. Du, Z., Y. Shen, W. Yang, I. Mecklenbrauker, B. G. Neel, and L. B. Ivashkiv. 2005. Inhibition of IFN-alpha signaling by a PKC- and protein tyrosine phosphatase SHP-2-dependent pathway. Proc. Natl. Acad. Sci. USA 102: 10267-10272. (Pubitemid 41023361)
31. Yoshimura, A., T. Naka, and M. Kubo. 2007. SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7: 454-465. (Pubitemid 46834848)
32. Malakhov, M. P., O. A. Malakhova, K. I. Kim, K. J. Ritchie, and D.-E. Zhang. 2002. UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J. Biol. Chem. 277: 9976-9981. (Pubitemid 34968105)
33. Malakhova, O. A., M. Yan, M. P. Malakhov, Y. Yuan, K. J. Ritchie, K. I. Kim, L. F. Peterson, K. Shuai, and D.-E. Zhang. 2003. Protein ISGylation modulates the JAK-STAT signaling pathway. Genes Dev. 17: 455-460. (Pubitemid 36258760)
34. Ritchie, K. J., C. S. Hahn, K. I. Kim, M. Yan, D. Rosario, L. Li, J. C. de la Torre, and D.-E. Zhang. 2004. Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection. Nat. Med. 10: 1374-1378. (Pubitemid 40022720)
35. Knobeloch, K.-P., O. Utermöhlen, A. Kisser, M. Prinz, and I. Horak. 2005. Reexamination of the role of ubiquitin-like modifier ISG15 in the phenotype of UBP43-deficient mice. Mol. Cell. Biol. 25: 11030-11034. (Pubitemid 41747144)
36. Malakhova, O. A., K. I. Kim, J.-K. Luo, W. Zou, K. G. S. Kumar, S. Y. Fuchs, K. Shuai, and D.-E. Zhang. 2006. UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity. EMBO J. 25: 2358-2367. (Pubitemid 44012219)
37. Gerber, J. S., and D. M. Mosser. 2001. Reversing lipopolysaccharide toxicity by ligating the macrophage Fc gamma receptors. J. Immunol. 166: 6861-6868. (Pubitemid 32467232)
38. Brown, G. D., J. Herre, D. L. Williams, J. A. Willment, A. S. J. Marshall, and S. Gordon. 2003. Dectin-1 mediates the biological effects of beta-glucans. J. Exp. Med. 197: 1119-1124. (Pubitemid 36570067)
39. Biondo, C., G. Signorino, A. Costa, A. Midiri, E. Gerace, R. Galbo, A. Bellantoni, A. Malara, C. Beninati, G. Teti, and G. Mancuso. 2011. Recognition of yeast nucleic acids triggers a host-protective type I interferon response. Eur. J. Immunol. 41: 1969-1979.
40. Pamer, E. G. 2004. Immune responses to Listeria monocytogenes. Nat. Rev. Immunol. 4: 812-823. (Pubitemid 39336297)
41. Turnbull, I. R., and M. Colonna. 2007. Activating and inhibitory functions of DAP12. Nat. Rev. Immunol. 7: 155-161. (Pubitemid 46174861)
42. Ananieva, O., J.Darragh, C. Johansen, J. M.Carr, J. McIlrath, J. M. Park, A.Wingate, C. E. Monk, R. Toth, S. G. Santos, et al. 2008. The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling. Nat. Immunol. 9: 1028-1036.
43. Kim, C., Y. Sano, K. Todorova, B. A. Carlson, L. Arpa, A. Celada, T. Lawrence, K. Otsu, J. L. Brissette, J. S. C. Arthur, and J. M. Park. 2008. The kinase p38 alpha serves cell type-specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression. Nat. Immunol. 9: 1019-1027.
44. Schett, G., J. Zwerina, and G. Firestein. 2008. The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis. Ann. Rheum. Dis. 67: 909-916. (Pubitemid 351956650)
45. Ivashkiv, L. B. 2008. A signal-switch hypothesis for cross-regulation of cytokine and TLR signalling pathways. Nat. Rev. Immunol. 8: 816-822.
46. Abram, C. L., and C. A. Lowell. 2009. The ins and outs of leukocyte integrin signaling. Annu. Rev. Immunol. 27: 339-362.
47. Nimmerjahn, F., and J. V. Ravetch. 2008. Fcgamma receptors as regulators of immune responses. Nat. Rev. Immunol. 8: 34-47.
48. Kelly, E. K., L. Wang, and L. B. Ivashkiv. 2010. Calcium-activated pathways and oxidative burst mediate zymosan-induced signaling and IL-10 production in human macrophages. J. Immunol. 184: 5545-5552.